Ayala Pharmaceuticals Inc (ADXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADXS | BMY | AMGN | GILD | VRTX |
| Company | Ayala Pharmaceuticals Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.6431 | 43.97 | 274.18 | 65.32 | 392.81 |
| High | 0.6431 | 44.47 | 279.84 | 65.89 | 406.95 |
| Low | 0.6431 | 43.73 | 273.38 | 64.97 | 392.47 |
| Last | 0.6431 | 44.21 | 277.37 | 65.51 | 402.14 |
| Change | -0.0219 | +0.27 | +3.43 | +0.31 | +9.33 |
| % Change | -3.29% | +0.61% | +1.25% | +0.48% | +2.38% |
| Volume | 266 | 13,243,044 | 2,322,158 | 7,072,300 | 1,236,092 |
| 20-Day Average Volume | 2,753 | 14,065,242 | 2,240,759 | 7,425,765 | 998,480 |
| Previous Close | 0.6650 | 43.94 | 273.94 | 65.20 | 392.81 |
| Industry | Medical - Drugs | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.6070 | 48.21 | 269.69 | 67.33 | 398.90 |
| 20-Day Raw Stochastic | 71.55% | 5.77% | 87.11% | 13.02% | 51.46% |
| 20-Day Relative Strength | 50.09% | 28.67% | 52.79% | 32.15% | 47.81% |
| Weighted Alpha | -62.97 | -36.23 | +14.56 | -21.43 | +14.78 |
| Today's Opinion | 72% Sell | 88% Sell | 24% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 88% Sell | 88% Sell | 40% Sell | 100% Sell | 24% Sell |
| Last Month's Opinion | 100% Sell | 8% Sell | 8% Sell | 88% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +19.09% since 04/23/24 | -9.52% since 04/24/24 | +1.60% since 04/24/24 | -2.34% since 04/24/24 | +0.34% since 04/24/24 |
| Low | 0.5400 on 04/24/24 | 43.73 on 05/01/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 391.70 on 04/30/24 |
| High | 0.6650 on 04/29/24 | 47.50 on 04/25/24 | 279.84 on 05/01/24 | 67.90 on 04/25/24 | 406.95 on 05/01/24 |
| 1-Month | |||||
| %Chg | +0.48% since 03/28/24 | -16.57% since 04/01/24 | -2.00% since 04/01/24 | -10.11% since 04/01/24 | -4.36% since 04/01/24 |
| Low | 0.5000 on 04/18/24 | 43.73 on 05/01/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 |
| High | 0.7000 on 04/05/24 | 53.35 on 04/02/24 | 283.91 on 04/02/24 | 72.85 on 04/02/24 | 420.87 on 04/02/24 |
| 3-Month | |||||
| %Chg | +10.88% since 02/01/24 | -9.16% since 02/01/24 | -14.54% since 02/01/24 | -16.18% since 02/01/24 | -7.31% since 02/01/24 |
| Low | 0.5000 on 04/18/24 | 43.73 on 05/01/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 |
| High | 1.4900 on 02/06/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 77.99 on 02/02/24 | 437.00 on 02/27/24 |
| 6-Month | |||||
| %Chg | -19.61% since 11/01/23 | -13.79% since 11/01/23 | +6.34% since 11/01/23 | -18.31% since 11/01/23 | +8.88% since 11/01/23 |
| Low | 0.5000 on 04/18/24 | 43.73 on 05/01/24 | 260.52 on 11/21/23 | 64.63 on 04/26/24 | 341.90 on 11/16/23 |
| High | 1.4900 on 02/06/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 7,150 | 89,070,768 | 146,934,848 | 81,179,024 | 101,525,288 |
| Shares Outstanding, K | 10,752 | 2,027,100 | 536,376 | 1,245,077 | 258,459 |
| Annual Sales | 10,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -48,070,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 11,865,000,000 | 8,196,000,000 | 6,686,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -7,340,000 | -11,911,000,000 | 767,000,000 | -4,170,000,000 | 968,800,000 |
| 60-Month Beta | 1.62 | 0.39 | 0.58 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.96 on 04/16/24 | -4.40 on 04/25/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 02/19/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 42.51 | 14.82 | 16.36 | 29.48 |